Ozempic and other similar medications have quickly become household names, offering effective treatments for type 2 diabetes and weight loss. But behind the headlines and excitement lies a more troubling reality. Across the country, individuals are stepping forward after suffering devastating side effects, from severe gastrointestinal complications to sudden vision loss.
If you or a loved one has been impacted, you deserve clear answers, trusted support, and the chance to understand your legal options. Let’s break down the key facts behind the Ozempic litigation, explain who may qualify, and outline what to expect if you decide to proceed with a claim.
Patients across the U.S. are pursuing legal action after experiencing serious side effects from Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), a class of medications that includes:
GLP-1 drugs work by mimicking the natural GLP-1 hormone in the body, which helps regulate blood sugar, stimulate insulin production, and slow digestion. While originally developed to help manage type 2 diabetes, many GLP-1 RAs have surged in popularity as weight loss treatments, leading to widespread use across the U.S. However, as usage has skyrocketed, troubling reports have emerged linking these drugs to serious gastrointestinal (GI) injuries, vision-related complications like NAION (non-arteritic anterior ischemic optic neuropathy), and other health risks.
Plaintiffs allege that the drug manufacturers failed to adequately warn patients and healthcare providers about the risks associated with these medications. In response to the rising number of lawsuits, the Judicial Panel on Multidistrict Litigation (JPML) created Multidistrict Litigation (MDL) No. 3094, officially titled Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation, currently active in the Eastern District of Pennsylvania. The litigation is actively evolving as new scientific studies and patient reports emerge.
Although GLP-1 medications have helped many patients manage type 2 diabetes and weight loss, growing evidence has revealed that these drugs may also carry serious and sometimes life-altering health risks. Here’s an overview of the major injuries and complications currently under investigation:
Vision-Related Complications: Emerging research has raised alarm over a potential link between GLP-1 drugs and NAION (non-arteritic anterior ischemic optic neuropathy), a rare but devastating eye condition that reduces blood flow to the optic nerve, causing sudden and often permanent vision loss. It’s important to note that NAION is different from diabetic retinopathy, which is a separate diabetes-related eye condition. While NAION affects the optic nerve, diabetic retinopathy damages the retina, the light-sensitive tissue at the back of the eye, due to chronic high blood sugar levels. Diabetic retinopathy typically develops gradually, causing vision changes like blurred vision or floaters, whereas NAION tends to happen abruptly and cause permanent vision loss. Recognizing this distinction is critical for patients, as the underlying causes, progression, and legal implications of these conditions are very different.
Gastrointestinal (GI) Injuries: Severe gastrointestinal complications linked to GLP-1 medications include gastroparesis (stomach paralysis), persistent vomiting, and bowel obstruction/blockage. These conditions can result in prolonged hospital stays, invasive procedures, feeding tube placement, and long-term disability.
Other Serious Side Effects: Patients and researchers have also reported additional potential risks associated with GLP-1 RA use, including pancreatitis, gallbladder disease or gallstones, deep vein thrombosis (DVT), pulmonary embolism (PE), increased risk of thyroid tumors, and hypoglycemia.
Currently, vision-related injuries like NAION are not yet part of the MDL. The Judicial Panel on Multidistrict Litigation (JPML) ruled to keep the MDL narrowly focused on GI-related claims, such as gastroparesis, for efficiency and manageability. If further evidence validates the connection between GLP-1 drug use and increased risk of NAION, the scope of the MDL may expand, or a new, separate MDL could be created specifically for vision loss cases.
Patients who have suffered vision-related injuries still have legal options to pursue compensation. Here's what you should know:
If you or a loved one has experienced serious health complications after using Ozempic or similar GLP-1 drugs, you may be eligible to take legal action. You may qualify for a lawsuit if you meet one or more of the following criteria:
The Ozempic and GLP-1 lawsuits are about far more than individual financial settlements. They represent an opportunity to create meaningful change and provide justice for thousands of patients and families harmed by these medications. Here’s why this litigation is so important:
It's completely natural to have concerns about joining a lawsuit, especially when you're already coping with serious health issues. Here's what you should know to help ease some common worries.
1. “I’m already dealing with health issues, will a lawsuit add more stress?"
It's understandable to worry that a lawsuit will add to your burden. The good news is that once you hire an attorney, they handle the legal work for you. Your legal team will handle court filings, negotiations, and evidence gathering. Your primary role is to provide initial medical details, and your day-to-day involvement is typically minimal. Many clients actually report feeling relieved once their case is in their attorney's hands, as they finally have someone advocating for them.
2. “Will I have to relive my trauma in court?”
For MDL cases, only a handful of plaintiffs ever go to trial, and most others settle or resolve without a courtroom appearance. If you're filing an individual vision loss claim, you may need to provide a statement or participate in a deposition (a formal interview), but these usually happen in a private, supportive setting, not a public courtroom. Even if you are ever asked to testify, your attorney will fully prepare you and support you every step of the way.
3. “What about my privacy? I don’t want my health details made public.”
Privacy matters, and it's protected. Your medical details are generally shared only between the parties involved, under strict confidentiality rules. Courts often issue protective orders to keep sensitive information private, and public records rarely highlight individual names. Unless you choose to share your story publicly, it’s unlikely anyone outside the legal process will even know you’re part of a lawsuit.
4. “How much of my time will this take?”
Your time commitment is minimal after the intake and document gathering process. You may occasionally need to answer follow-up questions, sign documents, or review paperwork. If your case proceeds to a deposition, that may take a few hours or a day, but many cases are resolved long before that point.
5. “Will suing affect my relationship with my doctors?”
Your lawsuit is against the drug manufacturers, not your doctors. Many healthcare providers were unaware of the potential risks, just like patients. Filing a claim won't negatively affect your medical care, relationship with your providers, or insurance coverage. Most doctors understand that patients have a right to pursue legal remedies if harmed.
6. “What if my health improves? Will that hurt my case?”
Even if your symptoms improve over time, you may still be entitled to compensation for the harm you’ve already endured. The legal process considers the full impact of your past injuries, including the pain you suffered, the medical expenses you faced, and the disruptions to your daily life.
The idea of being involved in a lawsuit can be intimidating, especially if you’ve never been involved in legal action before. Here’s a rundown of what patients can generally expect after deciding to file a claim in the Ozempic/GLP-1 litigation:
As a nationally recognized pharmaceutical litigation firm, Napoli Shkolnik has decades of experience holding major drug manufacturers accountable. We’ve helped thousands secure the compensation they deserve and are ready to do the same for you. Here’s why so many people trust Napoli Shkolnik to handle their pharmaceutical injury cases.
Whether you're considering joining the current GLP-1 MDL (focused on gastrointestinal injuries) or filing an individual claim for vision loss, remember this: you are not alone. Thousands of patients across the country are seeking justice and demanding accountability. By stepping forward, you not only fight for your own rights but also help protect the safety of others. Your case contributes to a broader push for justice, transparency, and responsibility in healthcare.
If you or a loved one has been affected by Ozempic or other GLP-1 medications, it’s important to take action now. Acting early ensures you meet important legal deadlines and maximizes your chance of securing the compensation you deserve.
Contact us for a free, confidential consultation. Our experienced legal team is here to listen to your story, explain your legal options, and guide you through every step of the process. Let Napoli Shkolnik help you move forward with the strength, care, and legal experience you can trust.
Attorney Advertising. The information on this website is for general information purposes only. Nothing on this site should be taken as legal advice for any individual case or situation. This information is not intended to create, and receipt or viewing does not constitute, an attorney-client relationship. Past outcomes mentioned on this site do not guarantee future results.